Albany, NY, June 21, 2016 (GLOBE NEWSWIRE) -- In a new report, titled “Neurovascular Intervention Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” Transparency Market Research provides a comprehensive overview of the global neurovascular intervention market. It covers various factors related to the market such as its development status, strategies adopted by leading enterprises, segmentation based on various parameters, product portfolio, and the growth drivers and restraints influencing its growth trajectory between 2013 and 2019.
Download PDF Brochure for Technical Insights:http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1687
Neurovascular intervention refers to the diagnosis, treatment, rehabilitation, and prevention of vascular disorders that affect the central nervous system with minimally invasive technologies or procedures. Neurovascular disorders are usually treated using micro catheters for recanalization or emolization of abnormal vessels.
Rising obesity has been a serious concern worldwide, spurring the incidence of many chronic ailments. The high prevalence of obesity in developed economies has urged their governments to focus on devising effective treatment plans for tackling ailments caused due to an unhealthy lifestyle and the increasingly prevalent neurological disorders. This has been a key factor driving the global neurovascular intervention market.
Regionally, North America dominated the global neurovascular intervention market, trailed by Europe. Growth witnessed by the market in North America is contributed by the increasing aging population and the growing prevalence of obesity in the region. However, during the forecast period, emerging economies in Latin America such as Argentina, Chile, and Brazil and in Asia Pacific such as India, Japan, and China are expected to show the fastest rate of growth. The rising gross domestic product and the increasing spending by healthcare institutions will boost the neurovascular intervention market in these regions.
The rising population of patients suffering from neurological disorders has been the primary factor boosting global neurological intervention market. Other major factors propelling the market include the introduction of the latest advancements in devices and treatment technology and the increasing incidence of hemorrhagic and ischemic strokes. The market is also substantially gaining from the rising demand for minimally invasive surgical procedures, market consolidation, and product innovation by leading enterprises. However, the high cost of this treatment can hamper the global neurovascular intervention market to an extent.
Some of the most prominent enterprises operating in the market include Abbott Laboratories, Boston Scientific Corporation, Flexible Stenting Solutions, Chestnut Medical Technologies, Inc., ITGI Medical Ltd., Stryker Corporation, Johnson & Johnson, Sequent Medical, Inc., and Terumo Corporation. The report aims at providing insights into the strengths and weaknesses of the companies profiled and study the threats and opportunities that these companies may face in the forthcoming years.
Trending Reports by TMR:
- Medical Automation Market: http://www.transparencymarketresearch.com/medical-automation-market.html
- Medical Device Technologies Market: http://www.transparencymarketresearch.com/medical-device-technologies-market.html
About Us:
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.